Responding to what it calls an “acute need” among clients for market access counsel, GfK is buying Bridgehead International, a consultancy with offices here and abroad.
People news: Novartis, Qforma and Precision Health Media
March 1, 2012
8:27 pm
Novartis named Brian McNamara as division head of OTC, replacing J&J veteran Naomi Kelman, who spent a year in the role.
Legislative wins, but no surety for survey researchers
Privately held inVentiv Health will acquire two of SDI Health’s audit businesses worth under $15 million, according to company statements. IMS Health agreed to divest the units when regulators approved its purchase of SDI last year.
Aiming for more real-world data, AZ cozies up to IMS Health
AstraZeneca has enlisted data supplier IMS Health in an effort to collect evidence on how its treatments are doing outside of controlled clinical trials, firms said.
Company news: Physicians Interactive, WorldOne, Bristol-Myers Squibb and Inhibitex
January 10, 2012
8:56 pm
Physicians Interactive (PI) and WorldOne formed an exclusive strategic alliance to merge their US-based healthcare marketing research panels, firms said.
Two powers of the marketing research arena—Epocrates and M3—partnered today to create what they claim is the world’s largest verified physician and healthcare provider panel.
Company news: Gilead, Pfizer and Wolters Kluwer
December 29, 2011
6:03 pm
Two potential blockbusters in the pharma pipeline took another step toward reaching market, as US regulatory authorities assigned PDUFA dates for Gilead Sciences’ Quad pill and for Pfizer’s tofacitinib.
Incivek’s $1 bil. in sales this year would set record for fastest launch, analyst says
Vertex’s drug for treating hepatitis C virus, Incivek (telaprevir), is on course to smash the previous record for the biggest revenue-generating drug launch ever, says an analyst firm.
IMS Health closes SDI deal, must divest two SDI product lines